Showing Form 4 filings for ADRX
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Adarx Pharmaceuticals, Inc.
Price
$17.00
Shares
61,516
Ownership
9,292,025
Value/Share
Chimovits Erez
Dir
Industry
950,000
588,235
Gordon Carl L
Dir, 10%
Orbimed Advisors LLC
1,600,000
9,936,661
Sr One Capital Management, LLC
10%
George Simeon